Herbalife's Shares Surge 7.2% on Beta Launch of Pro2col Platform
ByAinvest
Tuesday, Aug 19, 2025 3:49 pm ET1min read
HLF--
The Pro2col platform collects detailed user data, including nutritional goals and sleep quality, to suggest targeted products and improve customer retention. Herbalife plans a full commercial release in the U.S. and Puerto Rico during the fourth quarter of 2025, with further international expansion planned for 2026 [1].
The company's shares, which are known for their volatility, saw a significant rise on this news. However, the market considers this development meaningful but not a fundamental change to its perception of the business [1]. Herbalife is up 43.1% year-to-date (YTD) but is currently trading 11.7% below its 52-week high of $10.83 [1].
In the second quarter of 2025, Herbalife reported net sales of $1.3 billion, a 1.7% year-over-year (YoY) decline, and adjusted EBITDA of $173.6 million, which exceeded guidance. The company increased its full-year 2025 net sales and adjusted EBITDA outlook while lowering capital expenditure (Capex) forecasts [2].
Mizuho lifted its price target on HLF from $8 to $9, maintaining a 'Neutral' rating, reflecting the company's ability to deliver solid results and raise guidance. However, the analyst acknowledged the challenges posed by foreign currency headwinds and the competitive landscape in the health and wellness sector [2].
Investors will have the opportunity to hear directly from Herbalife CEO Stephan Gratziani and CFO John DeSimone at the Barclays Global Consumer Staples Conference on September 2, 2025 [3].
References:
[1] https://www.tradingview.com/news/stockstory:041e6fa0a094b:0-herbalife-hlf-shares-skyrocket-what-you-need-to-know/
[2] https://www.morningstar.com/news/business-wire/20250819248772/herbalife-ceo-and-cfo-to-participate-in-barclays-global-consumer-staples-conference-on-september-2
[3] https://www.ainvest.com/news/herbalife-reports-q2-2025-results-raises-earnings-outlook-mizuho-lifts-pt-9-2508/
Herbalife (HLF) shares jumped 7.2% after the company shared positive preliminary results from the beta launch of its new Pro2col digital health and wellness platform. The platform has seen strong engagement, with over 7,000 distributors participating since July. Herbalife plans a full commercial release in Q4 2025 and international expansion in 2026. The company's shares are volatile, but this news is considered meaningful. Herbalife is up 43.1% YTD but trading 11.7% below its 52-week high.
Herbalife (HLF) shares experienced a 7.2% increase in the morning session following the company's announcement of positive preliminary results from the beta launch of its new Pro2col digital health and wellness platform. The platform, acquired in March, has shown strong engagement, with over 7,000 distributors participating since July [1].The Pro2col platform collects detailed user data, including nutritional goals and sleep quality, to suggest targeted products and improve customer retention. Herbalife plans a full commercial release in the U.S. and Puerto Rico during the fourth quarter of 2025, with further international expansion planned for 2026 [1].
The company's shares, which are known for their volatility, saw a significant rise on this news. However, the market considers this development meaningful but not a fundamental change to its perception of the business [1]. Herbalife is up 43.1% year-to-date (YTD) but is currently trading 11.7% below its 52-week high of $10.83 [1].
In the second quarter of 2025, Herbalife reported net sales of $1.3 billion, a 1.7% year-over-year (YoY) decline, and adjusted EBITDA of $173.6 million, which exceeded guidance. The company increased its full-year 2025 net sales and adjusted EBITDA outlook while lowering capital expenditure (Capex) forecasts [2].
Mizuho lifted its price target on HLF from $8 to $9, maintaining a 'Neutral' rating, reflecting the company's ability to deliver solid results and raise guidance. However, the analyst acknowledged the challenges posed by foreign currency headwinds and the competitive landscape in the health and wellness sector [2].
Investors will have the opportunity to hear directly from Herbalife CEO Stephan Gratziani and CFO John DeSimone at the Barclays Global Consumer Staples Conference on September 2, 2025 [3].
References:
[1] https://www.tradingview.com/news/stockstory:041e6fa0a094b:0-herbalife-hlf-shares-skyrocket-what-you-need-to-know/
[2] https://www.morningstar.com/news/business-wire/20250819248772/herbalife-ceo-and-cfo-to-participate-in-barclays-global-consumer-staples-conference-on-september-2
[3] https://www.ainvest.com/news/herbalife-reports-q2-2025-results-raises-earnings-outlook-mizuho-lifts-pt-9-2508/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet